BioScrip to Host Update Conference Call
January 24 2011 - 5:12PM
Business Wire
BioScrip (NASDAQ: BIOS) today announced that on Monday, January
31, 2011 at 5:00 PM Eastern Standard Time, Richard M. Smith,
President and Chief Executive Officer, and David W. Froesel,
Executive Vice President, Chief Financial Officer and Treasurer,
will provide an update on the Company’s ongoing strategic
assessment to improve financial and operational performance. A live
audio webcast of the event may be accessed at
http://event.on24.com/r.htm?e=281225&s=1&k=F40F8B406EEC34EBA87AE83ACFB7E16C.
Interested parties may participate in the conference call by
dialing (866) 464-2449 (US), or (973) 935-2840 (International),
5-10 minutes prior to the start of the call. Please reference
conference call ID number: 39798876. A replay of the conference
call will be available for 48 hours after the call's completion by
dialing (800) 642-1687 and entering conference call ID number:
39798876. An audio webcast and archive will also be available for
90 days under the “Investor Relations” section of the BioScrip
website at http://www.bioscrip.com.
About BioScrip
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national
provider of specialty pharmacy and home care products and services
that partners with patients, physicians, hospitals, healthcare
payors and pharmaceutical manufacturers to provide clinical
management solutions and delivery of cost-effective access to
prescription medications. Our services are designed to improve
clinical outcomes for chronic and acute healthcare conditions while
controlling overall healthcare costs.
Forward Looking Statements-Safe
Harbor
Statements contained in this press release that express a
belief, expectation, anticipation or intent are considered
forward-looking statements and are protected under the Safe Harbor
of Private Securities Litigation and Reform Act. These
forward-looking statements are based on information available to
the Company today, and the Company assumes no obligation to update
statements as circumstances change. These forward-looking
statements may involve a number of risks and uncertainties, which
may cause the Company's results to differ materially from such
statements.
Forward-looking statements are subject to inherent risks and
uncertainties surrounding future expectations generally and may
differ materially from actual future experience. Risks and
uncertainties that could affect forward-looking statements include
the failure to realize annualized cost savings associated with any
restructuring or cost reduction efforts, our ability to leverage
core competencies or maximize margins and operating cash flow
generation, and the risks described from time to time in the
Company’s reports filed with the SEC, including the Company’s
annual report on Form 10-K for the year ended December 31, 2009 and
the Company’s quarterly reports on Form 10-Q for the quarters ended
March 31, 2010, June 30, 2010 and September 30, 2010.
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Apr 2024 to May 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From May 2023 to May 2024